A successful case of oral molecularly targeted therapy with imatinib for peritoneal metastasis of a gastrointestinal stromal tumor

International Journal of Clinical Oncology

Volumn 8, Issue 3, 2003, Pages 180-183

  Kanda, Tatsuo ^a   Ohashi, Manabu ^a   Makino, Shigeto ^a   Kaneko, Kouji ^a   Matsuki, Atsushi ^a   Nakagawa, Satoru ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

C kit; Gastrointestinal stromal tumor (GIST); Imatinib; Molecularly targeted therapy; Peritoneal metastasis

Indexed keywords

BCR ABL PROTEIN; IMATINIB; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEG EDEMA; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM METASTASIS; PRIORITY JOURNAL; RECURRENT CANCER;

ADMINISTRATION, ORAL; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PIPERAZINES; PYRIMIDINES; RISK ASSESSMENT; STROMAL CELLS; TREATMENT OUTCOME;

EID: 0042305226     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-003-0321-0     Document Type: Article

References (11)

1. Miettinen M, Virolainen M, Sarlorm-Rikala M (1995) Gastrointestinal stromal tumors: value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 19:207-216
2. Goldman JM, Melo JV (2001) Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1084-1086
3. Kantarjian H, Sawyers C, Hochhaus A, et al. (2002) Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 346:645-652
4. Hirota S, Isozaki K, Moriyama Y, et al. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580
5. Joensuu H, Roberts P, Sarlorm-Rikala M, et al. (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344:1052-1056
6. van Oosteron AT, Judson I, Verweij J, et al. (2001) Safety and efficacy of imatinib in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 358:1421-1423
7. Demetri GD, von Meren M, Blanke CD, et al. (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472-480
8. Rosai J (1996) Gastrointestinal tract: stromal tumors. In: Rosai J (ed) Ackerman's surgical pathology, 8th ed. Mosby, St Louis, pp 645-647
9. Fukuda H, Saijo N (2001) Common toxicity criteria, version 2.0. Jpn J Cancer Chemother 28:1993-2027
10. Dematteo RP, Lewis JJ, Leung D, et al. (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51-58
11. Rubin BP, Singer S, Tsao C, et al. (2001) KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61:8118-8121